Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
BACKGROUND: An association between the sputum eosinophil count and the response to a 2 week course of prednisolone has previously been reported in patients with chronic obstructive pulmonary disease (COPD). Whether the response to inhaled corticosteroids is related to the presence of eosinophilic in...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2005
|
| _version_ | 1797086116143169536 |
|---|---|
| author | Brightling, C McKenna, S Hargadon, B Birring, S Green, R Siva, R Berry, M Parker, D Monteiro, W Pavord, I Bradding, P |
| author_facet | Brightling, C McKenna, S Hargadon, B Birring, S Green, R Siva, R Berry, M Parker, D Monteiro, W Pavord, I Bradding, P |
| author_sort | Brightling, C |
| collection | OXFORD |
| description | BACKGROUND: An association between the sputum eosinophil count and the response to a 2 week course of prednisolone has previously been reported in patients with chronic obstructive pulmonary disease (COPD). Whether the response to inhaled corticosteroids is related to the presence of eosinophilic inflammation is unclear. METHODS: A randomised, double blind, crossover trial of placebo and mometasone furoate (800 microg/day), each given for 6 weeks with a 4 week washout period, was performed in subjects with COPD treated with bronchodilator therapy only. Spirometric tests, symptom scores, chronic respiratory disease questionnaire (CRQ), and induced sputum were performed before and after each treatment phase. RESULTS: Ninety five patients were recruited of which 60 were randomised. Overall there were no treatment associated changes in forced expiratory volume in 1 second (FEV(1)), total CRQ, or sputum characteristics. After stratification into tertiles by baseline eosinophil count, the net improvement in post-bronchodilator FEV(1) increased with mometasone compared with placebo progressively from the least to the most eosinophilic tertile. The mean change in post-bronchodilator FEV(1) with mometasone compared with placebo in the highest tertile was 0.11 l (95% CI 0.03 to 0.19). This improvement was not associated with a fall in the sputum eosinophil count. CONCLUSIONS: An increased sputum eosinophil count is related to an improvement in post-bronchodilator FEV(1) following treatment with inhaled mometasone in COPD, but the improvement is not associated with a reduction in the sputum eosinophil count. |
| first_indexed | 2024-03-07T02:17:27Z |
| format | Journal article |
| id | oxford-uuid:a2c149ba-5d06-4738-ba90-0ea83d943ea5 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:17:27Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:a2c149ba-5d06-4738-ba90-0ea83d943ea52022-03-27T02:22:17ZSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a2c149ba-5d06-4738-ba90-0ea83d943ea5EnglishSymplectic Elements at Oxford2005Brightling, CMcKenna, SHargadon, BBirring, SGreen, RSiva, RBerry, MParker, DMonteiro, WPavord, IBradding, PBACKGROUND: An association between the sputum eosinophil count and the response to a 2 week course of prednisolone has previously been reported in patients with chronic obstructive pulmonary disease (COPD). Whether the response to inhaled corticosteroids is related to the presence of eosinophilic inflammation is unclear. METHODS: A randomised, double blind, crossover trial of placebo and mometasone furoate (800 microg/day), each given for 6 weeks with a 4 week washout period, was performed in subjects with COPD treated with bronchodilator therapy only. Spirometric tests, symptom scores, chronic respiratory disease questionnaire (CRQ), and induced sputum were performed before and after each treatment phase. RESULTS: Ninety five patients were recruited of which 60 were randomised. Overall there were no treatment associated changes in forced expiratory volume in 1 second (FEV(1)), total CRQ, or sputum characteristics. After stratification into tertiles by baseline eosinophil count, the net improvement in post-bronchodilator FEV(1) increased with mometasone compared with placebo progressively from the least to the most eosinophilic tertile. The mean change in post-bronchodilator FEV(1) with mometasone compared with placebo in the highest tertile was 0.11 l (95% CI 0.03 to 0.19). This improvement was not associated with a fall in the sputum eosinophil count. CONCLUSIONS: An increased sputum eosinophil count is related to an improvement in post-bronchodilator FEV(1) following treatment with inhaled mometasone in COPD, but the improvement is not associated with a reduction in the sputum eosinophil count. |
| spellingShingle | Brightling, C McKenna, S Hargadon, B Birring, S Green, R Siva, R Berry, M Parker, D Monteiro, W Pavord, I Bradding, P Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. |
| title | Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. |
| title_full | Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. |
| title_fullStr | Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. |
| title_full_unstemmed | Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. |
| title_short | Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. |
| title_sort | sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease |
| work_keys_str_mv | AT brightlingc sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT mckennas sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT hargadonb sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT birrings sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT greenr sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT sivar sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT berrym sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT parkerd sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT monteirow sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT pavordi sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease AT braddingp sputumeosinophiliaandtheshorttermresponsetoinhaledmometasoneinchronicobstructivepulmonarydisease |